Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8005222 | 0.81 | TSHR (0.31) | TSHRPPARDSMN1; SMN2 | |
| SCHEMBL98778 | 0.81 | PPARD (0.38) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL8820544 | 0.78 | TSHR (0.39) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL7490235 | 0.77 | TSHR (0.37) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL14105288 | 0.76 | TSHR (0.40) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL905270 | 0.75 | TSHR (0.36) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL6553791 | 0.75 | TSHR (0.36) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL3170237 | 0.75 | TP53 (0.38) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL11430886 | 0.74 | TP53 (0.41) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL10590583 | 0.74 | TSHR (0.41) | TSHRTP53TDP1PPARDCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108603018-B | Polycarbonate resin composition and molded article thereof | 三菱化学株式会社 | 2020-08-14 | — | — | CN | disclosed |
| CN-107849344-B | Polycarbonate resin compound | 华东理工大学 | 2020-07-10 | — | — | CN | disclosed |
| CN-107922720-B | Polycarbonate resin composition, method for producing same, and molded article | 华东理工大学 | 2020-06-19 | — | — | CN | disclosed |
| CN-107709458-B | Polycarbonate resin composition, method for producing same, and molded article | 华东理工大学 | 2020-06-19 | — | — | CN | disclosed |
| CN-107709459-B | Polycarbonate resin composition, method for producing same, and molded article | 华东理工大学 | 2020-06-19 | — | — | CN | disclosed |
| CN-107075099-B | Polycarbonate resin, molded article, and optical film | 三菱化学株式会社 | 2020-06-12 | — | — | CN | disclosed |
| CN-111171545-A | Polycarbonate resin composition, method for producing same, and molded article | 三菱化学株式会社 | 2020-05-19 | — | — | CN | disclosed |
| CN-107849345-B | Polycarbonate resin composition, method for producing same, and molded article | 三菱化学株式会社 | 2020-03-13 | — | — | CN | disclosed |
| US-20140034623-A1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| US-8586745-B2 | Switchable special effect substances | BASF SE (DE) | 2013-11-19 | — | — | US | disclosed |
| US-20110060113-A1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2011-03-10 | — | — | US | disclosed |
| US-20070154732-A1 | Dendrimer compound and organic luminescent device employing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110060113-A1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | PPARG, PTGER4, NR2E3 | TSHR 1489/4885TP53 2844/4885TDP1 3584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.